Immuneering

(NASDAQ) IMRX

Current Price$4.54

Market Cap$294.37M

Since IPO (2021)-74%

5 YearN/A

1 Year+132%

1 Month-16%

Immuneering Financials at a Glance

Market Cap

$294.37M

Revenue (TTM)

$0.00

Net Income (TTM)

-$54.44M

EPS (TTM)

-$1.17

P/E Ratio

-3.90

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.54

Volume

564

Open

$4.29

Price

$4.54

Volume

564

Open

$4.29

Previous Close

$4.55

Daily Range

$4.23 - $4.60

52-Week Range

$1.66 - $10.08

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.54

Volume

564

Open

$4.29

Previous Close

$4.55

Daily Range

$4.23 - $4.60

52-Week Range

$1.66 - $10.08

IMRX News

Immuneering Posts Narrower Loss in Q2

Motley Fool Markets TeamAug 13, 2025

healthcare lab treatment research scientist

Why Shares of Immuneering Jumped This Week

James HalleyMar 24, 2023

IMRX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immuneering

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Benjamin J. Zeskind, PhD, MBA

Website

www.immuneering.com

Headquarters

Cambridge, MA 02142, US

IMRX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-44%

Return on Capital

-0%

Return on Assets

-0%

Earnings Yield

-25.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$294.37M

Shares Outstanding

64.70M

Volume

564

Avg. Volume

1.30M

Financials (TTM)

Gross Profit

-$698.89K

Operating Income

-$59.38M

EBITDA

-$58.68M

Operating Cash Flow

-$45.34M

Capital Expenditure

-$142.23K

Free Cash Flow

-$45.49M

Cash & ST Invst.

$172.83M

Total Debt

$3.82M

Immuneering Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$180.48K

N/A

Gross Margin

0.00%

N/A

Market Cap

$294.37M

N/A

Market Cap/Employee

$5.45M

N/A

Employees

N/A

Net Income

-$13.46M

+10.5%

EBITDA

-$15.15M

+1.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$152.96B

+481174.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$3.32B

+88832.8%

Short Term Debt

$412.84M

+117009.3%

Return on Assets

-0.03%

N/A

Return on Invested Capital

-0.03%

N/A

Free Cash Flow

-$18.51M

-31.4%

Operating Cash Flow

-$18.43M

-30.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ENTAEnanta Pharmaceuticals, Inc.

ENTAEnanta Pharmaceuticals, Inc.$11.24-6.57%

NAUTNautilus Biotechnology, Inc.

NAUTNautilus Biotechnology, Inc.$2.58-3.73%

TRDAEntrada Therapeutics, Inc.

TRDAEntrada Therapeutics, Inc.$6.58-0.90%

ZURAZura Bio Limited

ZURAZura Bio Limited$3.86-5.85%

HUMAHumacyte, Inc.

HUMAHumacyte, Inc.$1.40+0.72%

ARCTArcturus Therapeutics Holdings Inc.

ARCTArcturus Therapeutics Holdings Inc.$7.60-0.65%

FHTXFoghorn Therapeutics Inc.

FHTXFoghorn Therapeutics Inc.$3.64+0.28%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$16.73-0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$37.00-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.19+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$86.56-0.01%

BBBlackBerry

BBBlackBerry$10.18-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.01+0.00%

RGTIRigetti Computing

RGTIRigetti Computing$24.10-0.10%

Questions About IMRX

What is the current price of Immuneering?

Immuneering is trading at $4.55 per share.

What is the 52-week range for Immuneering?

Over the past 52 weeks, Immuneering has traded between $1.66 and $10.08.

How much debt does Immuneering have?

As of the most recent reporting period, Immuneering reported total debt of $3.73M.

How much cash does Immuneering have on hand?

Immuneering reported $47.32M in cash and cash equivalents in its most recent financial results.

What is Immuneering’s dividend yield?

Immuneering does not currently have a dividend yield.

Immuneering

Immuneering Financials at a Glance

IMRX News

Immuneering Posts Narrower Loss in Q2

Why Shares of Immuneering Jumped This Week

IMRX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Immuneering

IMRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Immuneering Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMRX

What is the current price of Immuneering?

What is the 52-week range for Immuneering?

How much debt does Immuneering have?

How much cash does Immuneering have on hand?

What is Immuneering’s dividend yield?

Premium Investing Services